Home  ›  France  ›  ABL Diagnostics

ABL Diagnostics insider transactions

Healthcare · EPA · France
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter▲ buy   ▼ sell
€ 4.5€ 1.910 Apr09 Jul

Insiders were sellers over the last quarter — 3 sales, no buys — a net €462K of selling. Most recent filing: 06 Jul 2026.

Net insider flow · last quarter
-€462K0 buys · 3 sells
Insider profiles
+●.●% avg 3m · win rate

Transactions

DateInsiderRoleTypeValue
06 Jul 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administrationSell€162,001
02 Jun 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administrationSell€149,999
27 May 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administrationSell€149,991
13 Mar 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administration▼ Sell€150,001
12 Feb 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administration▼ Sell€309,311
30 Jan 2026Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administration▼ Sell€500,001
30 Jul 2025Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administration▼ Sell€500,001
24 Feb 2025Advanced Biological Laboratories SA Société AnonymeMembre du conseil d’administration▼ Sell€137,500
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at French-listed companies must disclose dealings in their company's shares to AMF. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.